日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A randomized, phase II study of sequential belimumab and rituximab in primary Sjögren's syndrome

一项随机、II期临床研究,评估贝利木单抗和利妥昔单抗序贯治疗原发性干燥综合征的疗效。

Mariette, Xavier; Barone, Francesca; Baldini, Chiara; Bootsma, Hendrika; Clark, Kenneth L; De Vita, Salvatore; Gardner, David H; Henderson, Robert B; Herdman, Michael; Lerang, Karoline; Mistry, Prafull; Punwaney, Raj; Seror, Raphaele; Stone, John; van Daele, Paul LA; van Maurik, André; Wisniacki, Nicolas; Roth, David A; Tak, Paul Peter

Quantifying disease activity in rheumatoid arthritis with the TSPO PET ligand (18)F-GE-180 and comparison with (18)F-FDG and DCE-MRI

利用TSPO PET配体(18)F-GE-180定量类风湿性关节炎的疾病活动度,并与(18)F-FDG和DCE-MRI进行比较

de Groot, Marius; Patel, Neel; Manavaki, Roido; Janiczek, Robert L; Bergstrom, Mats; Östör, Andrew; Gerlag, Danielle; Roberts, Alexandra; Graves, Martin J; Karkera, Yakshitha; Fernando, Disala; Mistry, Prafull; Walker, Adam; Wisniacki, Nicolas; Fryer, Tim D; Jimenez-Royo, Pilar

Long-Term Safety and Efficacy of Belimumab in Patients With Systemic Lupus Erythematosus: A Continuation of a Seventy-Six-Week Phase III Parent Study in the United States

贝利木单抗治疗系统性红斑狼疮患者的长期安全性和有效性:一项在美国开展的为期76周的III期母体研究的延续研究

Furie, Richard A; Wallace, Daniel J; Aranow, Cynthia; Fettiplace, James; Wilson, Barbara; Mistry, Prafull; Roth, David A; Gordon, David

A Study to Investigate the Efficacy and Safety of an Anti-Interleukin-18 Monoclonal Antibody in the Treatment of Type 2 Diabetes Mellitus

一项研究旨在探讨抗白细胞介素-18单克隆抗体治疗2型糖尿病的疗效和安全性

McKie, Elizabeth A; Reid, Juliet L; Mistry, Prafull C; DeWall, Stephen L; Abberley, Lee; Ambery, Philip D; Gil-Extremera, Blas

First administration of the Fc-attenuated anti-β amyloid antibody GSK933776 to patients with mild Alzheimer's disease: a randomized, placebo-controlled study

首次对轻度阿尔茨海默病患者使用Fc减弱的抗β淀粉样蛋白抗体GSK933776:一项随机、安慰剂对照研究

Andreasen, Niels; Simeoni, Monica; Ostlund, Henrik; Lisjo, Pia I; Fladby, Tormod; Loercher, Amy E; Byrne, Gerard J; Murray, Frances; Scott-Stevens, Paul T; Wallin, Anders; Zhang, Yinghua Y; Bronge, Lena H; Zetterberg, Henrik; Nordberg, Agneta K; Yeo, Astrid J; Khan, Shahid A; Hilpert, Jan; Mistry, Prafull C

Modulation of β-amyloid by a single dose of GSK933776 in patients with mild Alzheimer's disease: a phase I study

单次注射 GSK933776 对轻度阿尔茨海默病患者 β-淀粉样蛋白的调节作用:一项 I 期研究

Leyhe, Thomas; Andreasen, Niels; Simeoni, Monica; Reich, Arno; von Arnim, Christine Af; Tong, Xin; Yeo, Astrid; Khan, Shahid; Loercher, Amy; Chalker, Michelle; Hottenstein, Charles; Zetterberg, Henrik; Hilpert, Jan; Mistry, Prafull

Prolonged pharmacodynamic effects of S-0139, an intravenously administered endothelin A (ET) antagonist, in the human forearm blood flow model.

S-0139(一种静脉注射的内皮素 A (ET) 拮抗剂)在人体前臂血流模型中具有持久的药效学作用

Lunnon Martin W, Wallace Sharon M L, Palmer Joanne E, Francis-Lang Andrew, Laurijssens Bart E, Mistry Prafull, Albala Bruce, Nagafuji Toshiaki, Wilkinson Ian B, Maltby Kay